Precision Biosciences (DTIL) Net Margin Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 49,253.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 506.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -569.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7,218.00 |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | 4,915.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,915.00 |
| Dec 31, 2025 | 12,331.00 |
| Sep 30, 2025 | -15.37 Mn |
| Jun 30, 2025 | -11.66 Mn |
| Mar 31, 2025 | -7.21 Mn |
| Dec 31, 2024 | -323,711.00 |
| Sep 30, 2024 | -338,388.00 |
| Jun 30, 2024 | 1,949.00 |
| Mar 31, 2024 | 9,669.00 |
| Dec 31, 2023 | 22,456.00 |
| Sep 30, 2023 | 38,406.00 |
| Jun 30, 2023 | 298,873.00 |
| Mar 31, 2023 | 25,694.00 |
| Dec 31, 2022 | 23,520.00 |
| Sep 30, 2022 | 31,424.00 |
| Jun 30, 2022 | -35,790.00 |
| Mar 31, 2022 | -47,094.00 |
| Dec 31, 2021 | -17,191.00 |
| Sep 30, 2021 | 33,588.00 |
| Jun 30, 2021 | 66,253.00 |
| Mar 31, 2021 | 47,548.00 |